Daniel B. Marsili Sells 19,500 Shares of Colgate-Palmolive (CL) Stock

Colgate-Palmolive (NYSE:CL) insider Daniel B. Marsili sold 19,500 shares of the firm’s stock in a transaction that occurred on Monday, April 16th. The stock was sold at an average price of $71.85, for a total value of $1,401,075.00. Following the transaction, the insider now owns 77,935 shares in the company, valued at approximately $5,599,629.75. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.

Colgate-Palmolive stock opened at $69.77 on Friday. Colgate-Palmolive has a twelve month low of $67.86 and a twelve month high of $77.91. The company has a quick ratio of 1.00, a current ratio of 1.36 and a debt-to-equity ratio of 27.02. The company has a market cap of $63,224.85, a price-to-earnings ratio of 24.31, a P/E/G ratio of 2.72 and a beta of 0.74.

How to Become a New Pot Stock Millionaire

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, January 26th. The company reported $0.75 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.75. Colgate-Palmolive had a return on equity of 1,716.69% and a net margin of 13.10%. The company had revenue of $3.89 billion during the quarter, compared to analysts’ expectations of $3.92 billion. During the same period last year, the firm earned $0.75 EPS. The firm’s revenue for the quarter was up 4.6% on a year-over-year basis. research analysts forecast that Colgate-Palmolive will post 3.18 EPS for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, May 15th. Shareholders of record on Friday, April 20th will be given a dividend of $0.42 per share. This represents a $1.68 dividend on an annualized basis and a yield of 2.41%. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.40. The ex-dividend date is Thursday, April 19th. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 55.75%.

A number of institutional investors have recently bought and sold shares of CL. Point72 Asset Management L.P. acquired a new stake in shares of Colgate-Palmolive in the 3rd quarter valued at approximately $1,814,000. Advisor Group Inc. lifted its holdings in shares of Colgate-Palmolive by 24.5% in the 4th quarter. Advisor Group Inc. now owns 77,352 shares of the company’s stock valued at $5,838,000 after buying an additional 15,212 shares during the period. Pictet & Cie Europe SA lifted its holdings in shares of Colgate-Palmolive by 5.5% in the 3rd quarter. Pictet & Cie Europe SA now owns 123,000 shares of the company’s stock valued at $8,961,000 after buying an additional 6,400 shares during the period. Daiwa Securities Group Inc. lifted its holdings in shares of Colgate-Palmolive by 44.2% in the 3rd quarter. Daiwa Securities Group Inc. now owns 34,617 shares of the company’s stock valued at $2,522,000 after buying an additional 10,617 shares during the period. Finally, Commonwealth Bank of Australia lifted its holdings in shares of Colgate-Palmolive by 11.8% in the 3rd quarter. Commonwealth Bank of Australia now owns 634,577 shares of the company’s stock valued at $45,997,000 after buying an additional 67,213 shares during the period. 73.64% of the stock is owned by institutional investors.

CL has been the topic of a number of research reports. Zacks Investment Research downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Monday, January 15th. Jefferies Group restated a “hold” rating and set a $79.00 price target on shares of Colgate-Palmolive in a research note on Friday, January 26th. BNP Paribas downgraded Colgate-Palmolive from an “outperform” rating to an “underperform” rating in a research note on Tuesday, January 30th. Barclays set a $75.00 price target on Colgate-Palmolive and gave the stock a “hold” rating in a research note on Thursday, March 15th. Finally, Citigroup raised their price target on Colgate-Palmolive from $75.00 to $80.00 and gave the stock a “neutral” rating in a research note on Tuesday, January 30th. Three analysts have rated the stock with a sell rating, eleven have assigned a hold rating and four have assigned a buy rating to the company’s stock. Colgate-Palmolive currently has a consensus rating of “Hold” and an average target price of $77.91.

TRADEMARK VIOLATION WARNING: “Daniel B. Marsili Sells 19,500 Shares of Colgate-Palmolive (CL) Stock” was first posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this article on another site, it was illegally stolen and reposted in violation of United States & international trademark and copyright laws. The original version of this article can be accessed at https://www.dispatchtribunal.com/2018/04/20/daniel-b-marsili-sells-19500-shares-of-colgate-palmolive-cl-stock.html.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Insider Buying and Selling by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply